[Significance of pharmaco-psychiatric findings for basic biological psychiatric research].
D000928:Antidepressive Agents / Q000494:pharmacology; D001714:Bipolar Disorder / Q000188:drug therapy / Q000209:etiology; D002395:Catecholamines; D002746:Chlorpromazine / Q000494:pharmacology; D003677:Deficiency Diseases / Q000150:complications; D004195:Disease Models, Animal; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D008094:Lithium / Q000627:therapeutic use; D008960:Models, Psychological; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D011600:Psychopharmacology; D011618:Psychotic Disorders / Q000188:drug therapy / Q000209:etiology*; D011955:Receptors, Drug; D013329:Structure-Activity Relationship; D014149:Tranquilizing Agents / Q000494:pharmacology
D000928:Antidepressive Agents; D002395:Catecholamines; D008996:Monoamine Oxidase Inhibitors; D011955:Receptors, Drug; D014149:Tranquilizing Agents; D008094:Lithium; D007099:Imipramine; D002746:Chlorpromazine
Die Bedeutung pharmakopsychiatrischer Befunde für die biologisch-psychiatrische Grundalagenforschung.